Literature DB >> 11407978

alpha v beta 6 Integrin upregulates matrix metalloproteinase 9 and promotes migration of normal oral keratinocytes.

G J Thomas1, S Poomsawat, M P Lewis, I R Hart, P M Speight, J F Marshall.   

Abstract

The integrin alpha v beta 6 is a fibronectin receptor that is undetectable on normal keratinocytes in situ, but is increased significantly in wound healing and in culture-established keratinocytes, suggesting that it may promote changes associated with cell motility. Using normal human oral keratinocytes we have shown that cultured cells express relatively high levels of alpha v beta 6 and this integrin has a functional role in both cell adhesion and migration towards fibronectin. We provide experimental evidence that the increased expression of alpha v beta 6 by normal human oral keratinocytes results in coordinate changes, which promote a more migratory phenotype. Thus increased expression of alpha v beta 6 results in a fibronectin-dependent increase in pro-matrix metalloproteinase 9, matrix metalloproteinase 9 activity increases normal human oral keratinocyte migration, and this may be further dependent on plasmin activation. The results suggest a key role for alpha v beta 6 in these processes and indicate a coordinated link between alpha v beta 6 expression and upregulation of matrix metalloproteinase 9. It appears that alpha v beta 6 may function in normal human oral keratinocyte migration through matrix-metalloproteinase-9-dependent and -independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11407978     DOI: 10.1046/j.1523-1747.2001.01352.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  23 in total

Review 1.  Integrin-mediated regulation of epidermal wound functions.

Authors:  C Michael DiPersio; Rui Zheng; James Kenney; Livingston Van De Water
Journal:  Cell Tissue Res       Date:  2016-06-28       Impact factor: 5.249

Review 2.  Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistance.

Authors:  Hassan Yousefi; Mousa Vatanmakanian; Mojdeh Mahdiannasser; Ladan Mashouri; Nikhilesh V Alahari; Mohammad Rafiee Monjezi; Shahrzad Ilbeigi; Suresh K Alahari
Journal:  Oncogene       Date:  2021-01-08       Impact factor: 9.867

3.  Gene delivery of a mutant TGFβ3 reduces markers of scar tissue formation after cutaneous wounding.

Authors:  Simon N Waddington; Rachel Crossley; Vicky Sheard; Steven J Howe; Suzanne M K Buckley; Lynda Coughlan; David E Gilham; Robert E Hawkins; Tristan R McKay
Journal:  Mol Ther       Date:  2010-08-24       Impact factor: 11.454

Review 4.  Pathophysiology of fistula formation in Crohn's disease.

Authors:  Michael Scharl; Gerhard Rogler
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

5.  Stromal cell-derived factor-1 (SDF-1) enhances cells invasion by αvβ6 integrin-mediated signaling in ovarian cancer.

Authors:  Baoyao Xue; Weiguang Wu; Kan Huang; Tingting Xie; Xiaobo Xu; Hongju Zhang; Chunlei Qi; Junli Ge; Yuecheng Yu
Journal:  Mol Cell Biochem       Date:  2013-04-25       Impact factor: 3.396

6.  Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells.

Authors:  Melanie Rolli; Emilia Fransvea; Jan Pilch; Alan Saven; Brunhilde Felding-Habermann
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-21       Impact factor: 11.205

7.  Mice that lack matrix metalloproteinase-9 display delayed wound healing associated with delayed reepithelization and disordered collagen fibrillogenesis.

Authors:  Themis R Kyriakides; Drausin Wulsin; Eleni A Skokos; Philip Fleckman; Annalisa Pirrone; J Michael Shipley; Robert M Senior; Paul Bornstein
Journal:  Matrix Biol       Date:  2009-01-20       Impact factor: 11.583

Review 8.  Integrins as "functional hubs" in the regulation of pathological angiogenesis.

Authors:  Liangru Contois; Abebe Akalu; Peter C Brooks
Journal:  Semin Cancer Biol       Date:  2009-05-29       Impact factor: 15.707

9.  Synthesis and characterization of a high-affinity {alpha}v{beta}6-specific ligand for in vitro and in vivo applications.

Authors:  Shunzi Li; Michael J McGuire; Mai Lin; Ying-Horng Liu; Tsukasa Oyama; Xiankai Sun; Kathlynn C Brown
Journal:  Mol Cancer Ther       Date:  2009-05-12       Impact factor: 6.261

10.  The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy.

Authors:  Xinjie Lu; Dong Lu; Mike Scully; Vijay Kakkar
Journal:  Perspect Medicin Chem       Date:  2008-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.